作者更正：桃金娘通过抑制 APAF-1 的表达减轻卵巢缺血再灌注损伤

IF 3.3 4区医学 Q1 Medicine

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI:10.26355/eurrev_202407_36586

F Aşır, Ç Özgökce

{"title":"作者更正：桃金娘通过抑制 APAF-1 的表达减轻卵巢缺血再灌注损伤","authors":"F Aşır, Ç Özgökce","doi":"10.26355/eurrev_202407_36586","DOIUrl":null,"url":null,"abstract":"Eur Rev Med Pharmacol Sci 2023; 27 (6): 2182-2188-DOI: 10.26355/eurrev_202303_31751-PMID: 37013735, published on March 30, 2023. After publication, the authors have contacted the journal to correct and update information contained in the Acknowledgments section. Therefore, the Acknowledgments are corrected as follows: • This study was supervised by Prof. Dr. Engin Deveci. He has agreed and accepted the final version of the published article. All authors, including Prof. Dr. Engin Deveci, have agreed to this change and provided a confirmation letter signed by all parties. https://www.europeanreview.org/article/31751 There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 14","pages":"3972"},"PeriodicalIF":3.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Author Correction: Momordica charantia reduced ovarian ischemia - reperfusion injury by suppressing APAF-1 expression.\",\"authors\":\"F Aşır, Ç Özgökce\",\"doi\":\"10.26355/eurrev_202407_36586\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Eur Rev Med Pharmacol Sci 2023; 27 (6): 2182-2188-DOI: 10.26355/eurrev_202303_31751-PMID: 37013735, published on March 30, 2023. After publication, the authors have contacted the journal to correct and update information contained in the Acknowledgments section. Therefore, the Acknowledgments are corrected as follows: • This study was supervised by Prof. Dr. Engin Deveci. He has agreed and accepted the final version of the published article. All authors, including Prof. Dr. Engin Deveci, have agreed to this change and provided a confirmation letter signed by all parties. https://www.europeanreview.org/article/31751 There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.\",\"PeriodicalId\":12152,\"journal\":{\"name\":\"European review for medical and pharmacological sciences\",\"volume\":\"28 14\",\"pages\":\"3972\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European review for medical and pharmacological sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26355/eurrev_202407_36586\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202407_36586","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

Eur Rev Med Pharmacol Sci 2023; 27 (6)：2182-2188-DOI：10.26355/eurrev_202303_31751-PMID：37013735，发表于 2023 年 3 月 30 日。文章发表后，作者已联系本刊，要求更正和更新致谢部分的信息。因此，致谢部分更正如下：- 本研究由 Engin Deveci 教授博士指导。他已同意并接受所发表文章的最终版本。包括 Engin Deveci 教授在内的所有作者都同意这一修改，并提供了各方签署的确认函。https://www.europeanreview.org/article/31751 本文有修改之处。出版商对此造成的不便深表歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Author Correction: Momordica charantia reduced ovarian ischemia - reperfusion injury by suppressing APAF-1 expression.

Eur Rev Med Pharmacol Sci 2023; 27 (6): 2182-2188-DOI: 10.26355/eurrev_202303_31751-PMID: 37013735, published on March 30, 2023. After publication, the authors have contacted the journal to correct and update information contained in the Acknowledgments section. Therefore, the Acknowledgments are corrected as follows: • This study was supervised by Prof. Dr. Engin Deveci. He has agreed and accepted the final version of the published article. All authors, including Prof. Dr. Engin Deveci, have agreed to this change and provided a confirmation letter signed by all parties. https://www.europeanreview.org/article/31751 There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European review for medical and pharmacological sciences 医学-药学

CiteScore

5.30

自引率

6.10%

发文量

906

审稿时长

2-4 weeks

期刊介绍： European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)